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ABSTRACT 
The disease Yoshaapasmara is commonly found in females described in Madhava Nidana Parishista, Bhaishjya Ratnawali etc. In modern psychiatry it is 
known  as  hysterical  neurosis  (HN)  which  is  now  described  as  “conversion  and  dissociative  disorder.”  Although  presently  there  are  no  definitive 
etiopathogenesis, clinical manifestation and management but Ayurveda has described many herbal and herbo-mineral formulations for management of the 
same. “Sarpagandha Churna Yoga” is one of them. Total thirteen patient of hysterical neurosis were selected and given the trial drug in the form of capsule 
with milk. Effect of trial drug was assessed on the basis of symptomatic improvement in symptoms and psychometric assessment was done by two scales 
namely Middlesex Hospital Questionnaire (by O. N. Srivastava & V. K. Bhatt) and Adjustment Scale (By R.R.Tripathi). After three month of treatment it was 
found that the trial drug is very effective for the management of Yshaapasmara vis –a-vis Hysterical Neurosis.   
KeyWords: Yoshaapasmara, Parada, Gandhaka, Rasa Sindura, Sarpagandha Churna Yoga.  
 
INTRODUCTION 
Ayurveda has been written in the form of Astanga Ayurveda 
which  covers  all  the  medical,  surgical  and  psychological 
disabilities  and  their  management  by  various  treatment 
modalities  like  pharmacological,  non  pharmacological  and 
surgical means. A wide range of psychiatric conditions have 
been described in Ayurveda out of them Unmada (psychosis) 
and  Apasmara  (epilepsy)  are  the  major  psychological 
infirmity.  The  disease  Yoshaapasmara  /Apatantraka  / 
Yoshaapatantraka is commonly found in females described in 
Madhava  Nidana  Parishista,  Bhaishjya  Ratnawali  and 
Sharngadhara Samhita Parishista etc. There is no description 
of Yoshaapasmara available in Brihatrayee (Chraka Samhita, 
Susruta Samhita and Astanga Hridaya). Human is rational & 
emotional and is being influenced by even small change in 
any  spears  of  life  resulting  in  to  various  physical  and 
psychological  reactions  and  mostly  these  reactions  are 
unfavorable. The Man of present era is living under various 
adversities,  stresses,  strains  and  anxiety.  Various  types  of 
stresses like educational, social, official, economical, family 
and so many other type of stresses are present in the today’s 
life  style  which  are  responsible  for  lack  of  material 
happiness,  comforts  and  mental  peace.  Continuously 
changing  lifestyle  along  with  ever-riding  stressful 
psychological  conditions  contributes  to  most  of  the 
psychosomatic and psychiatric diseases. The idleness, sexual 
repression,  perverted  thoughts,  fears,  worries,  depression, 
traumatism  and  prolong  sickness  etc.  are  the  common 
causative  factors.  Since  every  person’s  brain  is  unique,  so 
also is its capacity to bear external changes. If the person is 
too sensitive, then there is a high chance that person might 
act hysterically to seemingly insignificant stimuli. Physical, 
emotional,  or  sexual  abuse  can  be  a  contributing  cause  of 
conversion disorder in both adults and children. Basing on 
similarity  in  clinical  features,  many  Ayurvedic  scholars 
equated  the  Yoshaapasmara  with  Apatantraka
1  which  is 
described in all major Ayurvedic texts. Word “Yosha” refers 
to female, due to more prevalence in female it is called as 
Yoshaapasmara
2 but it may occur in male also who had soft 
temperament like females or man who cannot able to bear the 
hard situation or events. Ayurvedic scholars have equated this 
clinical entity with hysterical neurosis (now an absolute term) 
and in modern psychiatry it is described as ‘conversion and 
dissociative  disorder’.  Hysteria  is  a  common  form  of  the 
emotional  reaction  in  which  a  patient  tends  to  act  out  of 
his/her mental control in a dramatic way. Brain behaves in 
such  a  way  to  attract  others  to  gain  sympathy.    The  term 
“conversion” was first used by Sigmund Freud (1893). The 
term  conversion  disorder
3  reflects  the  hypothesis  that  an 
unconscious  psychological  conflict  is  converted  in  to 
symbolic symptoms, thereby reducing anxiety and shielding 
the conscious self from a painful emotion and can be defined 
as disturbance of bodily functioning that does not conform to 
current concepts of the anatomy and physiology of the central 
or  the  peripheral  nervous  system.  It  typically  occurs  in  a 
setting of stress and produces considerable dysfunction. The 
proposed etiologies are suggesting that the symptoms resolve 
an  intrapsychic  conflict  expressed  symbolically  through  a 
somatic symptom. Symptoms may manipulate the behavior 
of  other  persons  and  elicit  attention,  sympathy,  and 
nurturance. Current theories about the etiology of conversion 
emphasize  the  role  of  communication.  People,  who  have 
difficulty  in  verbally  articulating  psychosocial  distress  for 
any  reason,  may  use  conversion  symptoms  as  a  way  of 
communicating  their  distress.  Hysteria  (comprising  of 
conversion,  dissociative  and  somatization  disorder)
4 
constitute about 6-15% of all outpatient diagnoses and 14-
20%  of  all  neurotic  disorder.  Approximately  5%-24%  of 
psychiatric  outpatient,  5%-14%  of  general  hospital  patient 
and 1%-3% of outpatient psychiatric referrals have a history 
of conversion symptoms. Life time prevalence of conversion 
disorder  varied  widely,  ranging  from  11/100000  to 
500/100000 in general population samples. This disorder is 
more frequent in women than in men, ratio varying from 2:1 
to  10:1.  Dissociation
5  is  an  altered  state  of  consciousness 
characterized by partial or complete disruption of the normal 
integration of a person’s normal conscious or psychological 
functioning. Dissociation is most commonly experienced as a Kumar Dileep et al. IRJP 2012, 3 (7) 
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subjective perception of one's consciousness being detached 
from  one's  emotions,  body  and/or immediate  surroundings. 
The  essential  feature  of  the  dissociative  disorder  is  a 
disruption  in  the  usually  integrated  functions  of 
consciousness,  memory,  identity,  or  perception.  The 
disturbance may be sudden or gradual, transient or chronic. 
According to International society  for study  of trauma and 
dissociation
6, some studies indicate that dissociation occurs 
in  approximately  two  to  three  percent  of  the  general 
population. Approximately 73% of individuals exposed to a 
traumatic incident will experience dissociative states during 
the  incident  or  in the hours,  days  and  weeks  following.  It 
begins  in  early  adulthood  and  has  been  diagnosed  more 
frequently  in  women  than  in  men.  Hysterical  disorders 
frequently  prove  to  be  actual  medical  or  neurological 
disorders,  which  makes  it  important  to  rule  out  these 
disorders  before  diagnosing  a  patient  with  hysterical 
disorders. Due to less awareness about disorder and clinical 
presentation,  it  seems  to  very  emergent  condition  for  a 
general  people.  This  condition  is  often  misdiagnosed  as 
neurological  (epileptic)  disorder
7  and  many  times  other 
medical  conditions  like  multiple  sclerosis  etc.  were  under 
diagnosed. Besides being a health problem, this disorder is 
also  responsible  for  social  and  economical  problems  for  a 
family.  Yoshaapasmara  is  very  difficult  to  treat  and  may 
occur in any stage  of reproductive age i.e. till menopause. 
Many  herbal  and  herbo-mineral  formulations  along  with 
other therapeutic measures like Yoga, Sattvavajaya etc. are 
suggested for the management of the Yoshaapasmara.  
SELECTION OF TRAIL DRUG-The selection of proper 
drug in the management of disease is very important because 
proper drug will never deceive the physician in the path of 
success. In Ayurveda, drug or diet articles that reverses or 
break  the  Samprapti  (pathogenesis)  without  producing  any 
side  effect  is  considered  as  ideal.  Drug  combinations  are 
envisaged  to  serve  synergistic  action,  combined  action, 
toxicity neutralization action and specific action. The selected 
drug i.e. Sarpagandha Churna Yoga
8 is taken from celebrated 
text book of Ayurvedic therapeutics i.e. Rasa Tantra Sara Va 
Siddha  Prayoga  Sangrha.  This  formulation  contains  Rasa 
Sindura and Sapagandha Churna.  
AIM AND OBJECTIVE- 
1-  To  prepare  the  herbo-mineral  formulation  by  the 
classical methods. 
2-  The  clinical  evaluation  of  Sarpagandha  Churna  Yoga 
for the management of Yoshaapasmara (H N). 
MATERIAL  AND  METHODS-  Drug  was  prepared  in 
Ayurvedic pharmacy and department of Rasa Shastra which 
contains 475 mg of Sarpagandha Churna and 25 mg of Rasa 
Sindura and filled in capsule. Rasa Sindura was prepared by 
classical method described in Rasa Tarangini (6/162-167).  
Ingredients   
Sarpagandha Churna- 475 mg 
Rasa Sindura- 25 mg (contain Shodhit Parada and Shodhit 
Gandhaka). 
Vatankura swarasa- Q.S. Triturating liquid used in making of 
Rasa Sindura. 
Method of Preparation- In present work following method
9 
is  used  for  preparation  of  Rasa  Sindura  (Rasa  Tarangini 
6/162-167) 
Parada         – 1 part 
Gandhaka                 – 2 parts 
Vatankur Swarasa   – Q.S. 
First  of  all  prepare  Kajjali  of  Parada  and  Gandhaka  and 
triturate  with  Vatankur  Swarasa  for  three  times  in  Khalva 
Yantra, after drying powdered it and fill in Kacakupi, cover it 
all around with cloth smeared with mud for 7 times up to its 
1/3rd. Place it in a Baluka Yantra and apply slow moderate 
and strong heat gradually by increasing the temperature. The 
mouth of the bottle which was open from the begning may be 
closed with cork prepared with chalk or brick according to 
size of mouth of bottle. The closing of bottle mouth should be 
done only when the extra Sulfur is burned completely and the 
fumes of Sulfur similar to Gorochan in colour, stops coming 
out from the mouth of bottle. The joint of cork and mouth 
should  be  sealed  properly  with molasses  and  lime  powder 
made in to paste with water. After this strong heat may be 
applied  for  at  least  two  more  hours  to  allow  the  prepared 
compound  to  sublime  and  adhere  in  to neck  of  bottle.  On 
cooling  the  sublimed  product  (Rasa  Sindura)  may  be 
collected  from  the  neck  of  bottle  having  the  red  colour 
similar to the rising sun. 
Administration  of  drug:  Sapagandha  Churna  Yoga  was 
given to patient in the dose 500 mg two times in a day, filled 
in capsule (Sarpagandha Churna 475mg + Rasa Sindura 25 
mg).  
Anupana - Milk/Water/Gulab Jala 
CLINICAL STUDY - Seventeen cases were selected from 
the  Kayachikitsa  O.P.D  and  I.P.D.  S.S.  Hospital  I.M.S. 
B.H.U.  Varanasi  and  out  of  them  four  case  were  dropout 
from  study.  Case  selection  was  random  regardless  of  age, 
sex, occupation and socioeconomic considerations.  
The exclusion criteria - Patients with following examination 
findings or history and clinical condition were excluded. 
·   Age below 12 year and above 45 years. 
·  Females after menopause. 
·  Patient with history of any significant physical illness e.g. 
tuberculosis,  diabetes  mellitus,  ischemic  heart  diseases, 
CVA. etc. 
·  Patient  having  any  diagnosed  significant  psychiatric 
illness or taking treatment. 
·  Patient  with  history  of  substance  abuse  e.g.  alcohol, 
cannabis etc. 
·  Patient having endocrine or metabolic disorders. 
·  Patient having significant history of head injury. 
·  Patient  having  significant  findings  in  lab  investigations 
like EEG, CT scan head.  
The  Inclusion  criteria-  Patient  who  fulfill  the  DSM  IV 
diagnostic  criteria  for  conversion  or  dissociative  disorder 
were selected along with other considerations like - 
·  Patients  ranging  between  12-45  years  of  age  were 
registered only. 
·  Females before menopause. 
·  Patients  having  no  significant  medical  illness  viz., 
hypertension,  diabetes  mellitus,  pulmonary  tuberculosis 
etc were registered only. 
·  Patients  having  no  significant  psychiatric  illness  viz. 
depression, schizophrenia etc. were registered only. 
·  Patients having no significant H/o surgical interventions 
viz. hysterectomy, neurosurgery spinal surgeries etc. were 
registered only. 
·  Patients having no significant H/o trauma viz. spinal cord 
injuries etc. were registered only. 
·  Patient not having any drug dependence or addiction like 
alcohol etc. 
·  Patient  having  no  significant  finding  in  different  lab 
investigations like EEG, CT scan of head etc. 
 
 Kumar Dileep et al. IRJP 2012, 3 (7) 
Page 176 
ASSESSMENT OF DRUG RESPONSE – 
Clinical  Assessment-  It  was  based  on  relief  found  in  the 
signs and symptoms of the disease. For this purpose main 
signs and symptoms were given a suitable score according to 
their severity before and after treatment. Study consisted of 
three follow ups, initially at 15 day interval for two follow-
ups  thereafter  two  follow-ups  of  one  month  interval  each. 
During each follow up patients were interviewed regarding 
symptomatic improvement, general examination, systematic 
examination and psychiatric examinations.  
Psychometric Assessment- following scales were used for 
this purpose - 
·  Middlesex  Hospital  Questionnaire  (M.H.Q.  –  O.  N. 
Srivastava And V. K. Bhatt  
·  Adjustment Scale  - By R.R.Tripathi  
The M.H.Q. is a short, clinical diagnostic self rating scale for 
psychoneurotic  patients,  constructed  by  Crown  and  Crisp 
(1966).  It gives  a  “quantitative  clinical  profile”  as the  test 
consists of six subscales having 8 questions each and study 
was  concentrated  on  Hysterical  personality  traits  (HYS) 
subscale. The Hindi version of the M.H.Q. is a very sensitive, 
reliable and valid instrument for differentiating the neurotics 
from normal. Hindi version was prepared by O.N.Sriwastava 
and  V.K.  Bhat,  Department  of  Psychiatry  I.M.S.  B.H.U. 
Varanasi (1973). In this study we have used an Adjustment 
Scale (Samayojana Suchika) prepared by Prof. R. R. Tripathi 
published  by  Raghuveer  Publication  Varanasi.  This  scale 
simply aims at screening an individual for minor departure 
from adjustmental norms the baseline for which must be in 
terms of dimensions of healthy adjustment.  
RESULT AND DISCUSSION 
Sarpagandha Churna Yoga is indicated
10 in the management 
of  insomnia,  Apatantraka  (hysterical  neurosis),  Unmada 
(psychosis),  hypertension  and  newly  diagnosed  epileptic 
disorders.  Rasa  Sindura
11  mainly  works  on  Kapha  Dosa, 
Rasa-Rakta-Mamsa  Dhatu,  Amashaya,  Hridaya  and 
Kaphasthana.  It  regulates  5  types  of  Vata  and  maintains 
proper functioning of nerves, hence gives pleasure to those 
who use it. It regulates the sense organs. Urine, feaces etc. 
waste  materials  are  excreted  from  the  body  without  any 
trouble. It is Pittasaraka and best among invigorating agents. 
It  is  Pramehahara  (antidiabetic)  and  also  works  on 
Rajayakshma  (tuberculosis),  Pandu  (aneamia) and  Sthaulya 
(obesity). Other properties like Medhya (intellect promoting), 
Parama  Rasayana,  Mutrala  (diuretic),  Dhatukriya-
Pravardhaka  (promoting  tissues  functions),  Hridya 
(cardiotonic),  Kamagni  Sandeepana  (aphrodiasic)  etc.  are 
mentioned  in  different  texts.  Rasa  Sindura  works  on 
Trimarma  (heart,  brain  and  bladder).  Rasa  Sindura  (Red 
sulphide of mercury) is promoter of ̎various enzymes. It also 
works on 5 types of Pitta, which are responsible for Deepana- 
Pachana (digestive and assimilative function), Raktavardhana 
(blood forming), Medha (intellect), Dristi (vision), Balakara 
(strength),  Kantivardhana  (lusture  promoting)  and 
Kusthahara (treating skin disorder). Parada
12 have Shadarasa 
and  Sara,  Guru,  Snigdha  Guna,  Ushna  Virya,  Madhura 
Vipaka  and  Tridosghna.  It  has  properties  like  Vrisya 
(aphrodiasic), Balya (strength forming), Rasayana, Yogavahi, 
Sarvarogajita  (treating all  disorders),  Shodhana  (purifying), 
Ropana  (healing)  and  Krimighna  (deworming).  Parada 
balances  the  Tridosa  (Tridosghna),  increases  Buddhi 
(intelligence),  Medha  (intellect),  Smriti  (memory),  Kanti 
(lusture),  Prabha  (glow)  and  Bala  (strength)  and  is  best 
aphrodisiac  (Mahavrisya).  Gandhaka
13  is  having  properties 
like  Kushtaghna,  Rasayana,  Pitta  vardhak and  Kapha  Vata 
hara. This element is present in many polypeptides, proteins, 
and  enzymes.  Sarpagandha
14  is  Kapha-Vata  shamaka, 
Mastiska  shamak,  Nidrajanan  (hypnotic),  Krimighna, 
Ampacaka and Hridayavasadak (cardiac depressant). It shows 
Anticholinergic,  Hypotensive,  Anticontractile,  Sedative, 
Relaxant, Hyperthermic, Antidiuretic, Hypnotic, Vasodilator, 
Antiemetic,  Nematicidal,  and  Antifungal  activity. 
Therapeutic  use  of  Sarpagandha  is  documented  in  various 
mental and neurological disorders like Unmada, Apasmara, 
Anidra etc. It is used as antihypertensive and Tranquilizer. It 
is first herbal antipsychotic drug.  Rauwolfia serpentina
15 had 
been sold as “Pagalpan Ki Jadi” (medicine for insanity) in 
folk medicine for centuries. This herb had been used as an aid 
to meditation, reportedly even by Mahatma Gandhi. The first 
report in the medical literature of the use of Rauwolfia was 
published in 1931 in an Indian Medical Journal by Gananath 
Sen and K. C. Bose. They reported that this drug reduces the 
blood  pressure,  and  also  improves  the  violent  maniac 
symptoms  and  also  documented  the  actions  like  hypnotic 
effect,  a  calming  effect  on  agitated,  mentally  deranged 
patients,  and  a  hypotensive  effect  in  arterial  hypertension. 
That  same  year,  1931,  two  Indian  chemists,  Siddiqui,  and 
Siddiqui, first extracted several alkaloids including Ajmaline 
and  Serpentine  from  Rauwolfia
15.  In  an  extensive  study 
published  in  the  prestigious  British  Heart  Journal  (1949), 
Rustom  Jal  vakil  reported  the  antihypertensive  effect  of 
Rauwolfia.  In  1954,  Nathan  Kline  reported  therapeutic 
efficacy of Reserpine in schizophrenia. Comparative effects
16 
of  Rauwolfia  vomitoria  and  chlorpromazine  on  locomotor 
behavior and anxiety in mice shows that the Root bark extract 
from Rauwolfia vomitoria produced better behavioral effects 
with less distortion in motor coordination when compared to 
chlorpromazine and so has a great potential as an alternative 
antipsychotic  agent  compared  to  chlorpromazine.  Since 
Reserpine  did  not  produce  same  effects  as  Rauwolfia 
vomitoria, the effect of Rauwolfia vomitoria may not be due 
solely  to  Reserpine  as  claimed.  Ajmaline
17,  a  Rauwolfia 
derivative, has been found to possess potent antiarrhythmic 
effects.  Ajmalin  is  an  effective  drug  for  the  treatment  of 
serious  digitalis-toxic  cardiac  arrhythmias.  Response  of 
patients to the therapeutic trial was assessed through clinical, 
physiological  and  psychometric  parameters.  Clinical 
assessment was done on the basis of statistical calculations. 
After treatment it was found that no statistically significant 
change  were  observed  in  speech,  attention,  concentration, 
memory, mood, Vyayama Sakti and Sattva. Although there 
was no significant changes were found but improvement was 
observed in symptoms like irregular bowel habit, paralysis, 
paresis  and  sensory  deficit.  After  treatment  statistically 
significant changes (improvement) was founded in symptoms 
like Ama (t=2.00, p<0.05) appetite (t=2.00, p<0.05), urinary 
retention/difficulty  in  micturition  (χ
2  =11.5  p<0.05),  and 
restlessness (χ
2=10.31, p<0.05) and highly significant results 
in  symptoms  like  muscle  cramps  (χ
2=14.5,  p<0.01), 
frequency of episodes of unconsciousness (χ
2=32.9,p<0.01), 
duration  of  unconsciousness  episodes  (χ
2=20.73,  p<0.01), 
abnormal  body  movements/tremors  (χ
2=17.95,  p<0.01)  and 
headache  (χ
2=22.72,  p<0.01).  There  was  a  very  good 
improvement was observed in case of some symptoms  but 
they  were  statistically  insignificant,  like  menstrual 
abnormality  in  females  (χ
2=4.00),  breathlessness  (χ
2=4.00), 
chest pain (χ
2=4.00) and pain abdomen (χ
2=8.00). Here it is 
necessary  to  mentioned  that  symptoms  of  specific 
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depersonalization etc. were not founds in any of registered 
patients.  In  this  series  under  psychometric  assessment  we 
have  use  two  scales  namely  Adjustment  Scale  by 
R.R.Tripathi and Middlesex Hospital Questionnaire (MHQ). 
It was observed that effect of trail treatment on adjustment 
scale (t=3.89, p<0.01 HS) that was highly significant. Now 
we can conclude that most of the patients were found more 
adjusted  than  earlier.  Effect  of  trail  treatment  on  MHQ 
(t=5.50, p<0.01 HS) was also highly significant.  
CONCLUSION 
Yoshaapasmara  vis-à-vis  hysterical  neurosis  commonly 
found in females is very difficult to treat due to its variable 
etiology  and  manifestation  in  different  patients.  Doshic 
involvement in Yoshaapasmara are Vata and Kapha and Rasa 
Sindura  is  having  the  Kapha  shamaka,  Parada  is  having 
Tridosghna, while Gandhaka and Sarpagandha are having the 
Vata-Kapha shamaka properties, which are the ingredient of 
trial  drug.    Rauwolfia  serpentina  is  established  herbal 
antipsychotic  drug  which  is  the  main  ingredient  of 
Sarpagandha  Churna  Yoga.  Although  it  is  time  bounded 
small  sample  study  but  it  was  found  that  it  is  the  very 
effective  formulation  for  the  management  of  hysterical 
neurosis and after treatment patients were more adjusted than 
earlier. The findings of this study enlighten the future clinical 
trial of this drug in insomnia, psychosis and newly diagnosed 
epileptic disorders. 
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